Ligand Pharmaceuticals reported $27.33M in Stock for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US $ 4411M 325M
Anika Therapeutics ANIK:US 35.22M 785K
Baxter International BAX:US $ 2548M 95M
Bristol Myers Squibb BMY:US $ 2104M 9M
Clovis Oncology CLVS:US $ 14.5M 0.82M
Eli Lilly And LLY:US $ 3893M 7M
Endo International Ordinary Shares ENDP:US $ 283.83M 0.27M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
Harsco HSC:US $ 76.85M 6.36M
Heron Therapeutics HRTX:US $ 56.47M 8.09M
Intrexon XON:US $ 12.73M 0.53M
Karyopharm Therapeutics KPTI:US $ 3.87M 232K
Lannett LCI:US $ 95.43M 10.34M
Macrogenics MGNX:US $ 4.6M 0.21M
Merk MRK:US $ 5774M 179M
Pacira Pharmaceuticals PCRX:US $ 103.66M 5.11M
Pfizer PFE:US $ 9979M 920M
Rigel Pharmaceuticals RIGL:US $ 6.76M 0.15M
Teva Pharmaceutical Industries TEVA:US $ 4012M 194M
Veracyte VCYT:US $ 12.37M 1.15M